IRIS
GIACOMETTI, Andrea
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 11.012
EU - Europa 5.830
AS - Asia 2.423
AF - Africa 189
Continente sconosciuto - Info sul continente non disponibili 12
SA - Sud America 11
OC - Oceania 7
Totale 19.484
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 10.980
UA - Ucraina 1.457
SG - Singapore 845
IE - Irlanda 826
SE - Svezia 780
IT - Italia 757
TR - Turchia 685
DE - Germania 628
DK - Danimarca 532
CN - Cina 506
FI - Finlandia 303
KR - Corea 287
FR - Francia 266
GB - Regno Unito 168
CI - Costa d'Avorio 164
IN - India 33
CA - Canada 30
IR - Iran 27
HK - Hong Kong 26
BE - Belgio 25
MA - Marocco 23
NL - Olanda 18
RU - Federazione Russa 16
EU - Europa 11
RO - Romania 9
RS - Serbia 9
CH - Svizzera 7
PL - Polonia 6
AR - Argentina 5
AT - Austria 4
AU - Australia 4
BG - Bulgaria 4
CL - Cile 4
JP - Giappone 4
MY - Malesia 3
NZ - Nuova Zelanda 3
CM - Camerun 2
CY - Cipro 2
CZ - Repubblica Ceca 2
ES - Italia 2
HR - Croazia 2
MX - Messico 2
A1 - Anonimo 1
AL - Albania 1
AZ - Azerbaigian 1
BR - Brasile 1
CO - Colombia 1
EE - Estonia 1
GR - Grecia 1
IL - Israele 1
IS - Islanda 1
LA - Repubblica Popolare Democratica del Laos 1
LK - Sri Lanka 1
LT - Lituania 1
LV - Lettonia 1
MD - Moldavia 1
NO - Norvegia 1
PT - Portogallo 1
VN - Vietnam 1
Totale 19.484
Salva come PNG Salva come JPEG
Città #
Jacksonville 1.488
Chandler 1.178
Fairfield 1.124
Dublin 816
Boardman 752
Ashburn 591
Wilmington 585
Woodbridge 486
Houston 386
Singapore 379
Seattle 372
Ann Arbor 368
New York 366
Des Moines 365
Cambridge 334
Lawrence 317
Princeton 317
San Mateo 312
Abidjan 164
San Diego 142
Centro 135
Turin 115
Beijing 82
Redmond 67
Guangzhou 44
Shanghai 44
Norwalk 43
Izmir 40
London 36
Los Angeles 34
Helsinki 29
Porto 28
Wuhan 27
Ancona 26
Washington 26
Brussels 25
Hong Kong 24
Pune 24
Falls Church 21
Ottawa 19
Wuxi 19
Dallas 18
Marche 17
Rome 16
Jiaxing 15
Kilburn 15
Civitanova Marche 14
Nanjing 13
Cingoli 12
Istia D'ombrone 11
Prescot 10
Saint Louis 10
Belgrade 9
North Bergen 9
Shenzhen 9
Dronten 8
Seoul 8
Buffalo 7
Chiswick 7
Fort Worth 7
Hounslow 7
Yiwu 7
Auburn Hills 6
Mcallen 6
Pergola 6
Pesaro 6
Toronto 6
Acton 5
Falconara Marittima 5
Hanover 5
Jesi 5
Moscow 5
San Benedetto del Tronto 5
Tolentino 5
Amsterdam 4
Boydton 4
Campobasso 4
Castelfiorentino 4
Clifton 4
Dalian 4
Macerata 4
Milan 4
New Bedfont 4
Quanzhou 4
Santa Clara 4
Santa Vittoria In Matenano 4
Squinzano 4
Vallefoglia 4
Venice 4
Zibo 4
Andover 3
Appignano 3
Auckland 3
Breda Di Piave 3
Chizhou 3
Delhi 3
Fayetteville 3
Fuzhou 3
Gdansk 3
Heze 3
Totale 12.138
Salva come PNG Salva come JPEG
Nome #
Comparative efficacy of topical versus systemic teicoplanin in experimental model of wound infections 204
Antimicrobial Resistance: A Challenge for the Future 162
Prophylactic efficacy of topical temporin A and RNAIII-inhibiting peptide in a subcutaneous rat pouch model of graft infection attributable to staphylococci with intermediate resistance to glycopeptides 139
BisEDT and RIP act in synergy to prevent graft infections by resistant staphylococci. 131
Citropin 1.1-treated central venous catheters improve the efficacy of hydrophobic antibiotics in the treatment of experimental staphylococcal catheter-related infection. 123
RNAIII-inhibiting peptide in combination with the cathelicidin BMAP-28 reduces lethality in mouse models of staphylococcal sepsis 118
Enhanced efficacy of combinations of pexiganan with colistin versus Acinetobacter baumannii in experimental sepsis 117
Efficacy of the quorum sensing inhibitor FS10 alone and in combination with tigecycline in an animal model of staphylococcal infected wound 115
Anticryptosporidial activity of paromomycin. 110
Protective effects of the combination alpha-helical antimicrobial peptides and rifampin in three rat models of Pseudomonas aeruginosa infection 104
Colistin enhances therapeutic efficacy of daptomycin or teicoplanin in a murine model of multiresistant Acinetobacter baumannii sepsis. 104
Activity of nitazoxanide alone and in combination with azithromycin and rifabutin against Cryptosporidium parvum in cell culture. 101
Tachyplesin III and Granulocyte-Colony Stimulating Factor Enhance the Efficacy of Piperacillin/Tazobactam in a Neutropenic Mouse Model of Polymicrobial Peritonitis 99
CD4/CD8 ratio normalisation and non-AIDS-related events in individuals with HIV who achieve viral load suppression with antiretroviral therapy: An observational cohort study 98
Antimicrobial activity of polycationic peptides 97
Tigecycline accelerates staphylococcal infected burn wound helaing through MMP-9 modlualtion 97
SARS-CoV-2 infection in kidney transplant recipients: Experience of the italian marche region 97
In vitro activity and in vivo animal model efficacy of IB-367 alone and in combination with imipenem and colistin against Gram-negative bacteria. 94
In-vitro activity of the synthetic protegrin IB-367 alone and in combination with antifungal agents against clinical isolates of Candida spp. 92
Cecropin B enhances betalactams activities in experimental rat models of gram-negative septic shock 92
Activity of buforin II alone and in combination with azithromycin and minocycline against Cryptosporidium parvum in cell culture. 90
In-vitro effect of short-term exposure to two synthetic peptides, alone or in combination with clarithromycin or rifabutin, on Cryptosporidium parvum infectivity. 90
Development of a definition for Rapid Progression (RP) of renal function in HIV-positive persons: The D:A:D study 89
First-line antiretroviral therapy with efavirenz plus tenofovir disiproxil fumarate/emtricitabine or rilpivirine plus tenofovir disiproxil fumarate/emtricitabine: a durability comparison 88
Antimicrobial properties of distinctin in an experimental model of MRSA-infected wounds. 87
Efficacy of pexiganan combination with tigecycline in a mouse model of Pseudomonas aeruginosa sepsis 87
Efficacy of the amphibian peptide distinctin in a neutropenic mouse model of staphylococcal sepsis 86
Effects of the Infusion of 4% or 20% Human Serum Albumin on the Skeletal Muscle Microcirculation in Endotoxemic Rats 86
Development and Validation of a Risk Score for Chronic Kidney Disease in HIV Infection Using Prospective Cohort Data from the D:A:D Study 85
High rate of ceftobiprole resistance among clinical methicillin-resistant Staphylococcus aureus isolates from a hospital in central Italy 85
In vitro activity of Protegrin-1, alone and in combination with clinically useful antibiotics, against Acinetobacter baumannii strains isolated from surgical wounds 85
Suppression of biofilm related, device-associated infections by staphylococcal quorum sensing inhibitors. 83
The Antimicrobial Peptide Tachyplesin III Coated alone and in Combination with Intraperitoneal Piperacillin-Tazobactam Prevents Ureteral Stent Biofilm Formation in a Rat Subcutaneous Pouch Model of Pseudomonas Infection. 83
Epidemiology and microbiology of surgical wound infections. 83
Inflammatory effects of atazanavir/ritonavir versus darunavir/ritonavir in treatment naïve, HIV-1-infected patients 83
ACTIVITY OF THE NEW ANTIFUNGAL TRIAZOLE, POSACONAZOLE, AGAINST CRYPTOCOCCUS NEOFORMANS 82
Therapeutic efficacy of the magainin analogue MSI-78 in different intra-abdominal sepsis rat models. 82
In vitro activity and in vivo efficacy of tigecycline alone and in combination with daptomycin and rifampin against Gram-positive cocci isolated from surgical wound infection. 82
Comparative efficacies of quinupristin-dalfopristin, linezolid, vancomycin, and ciprofloxacin in treatment, using the antibiotic-lock technique, of experimental catheter-related infection due to Staphylococcus aureus. 81
Trends in underlying causes of death in people with HIV from 1999 to 2011 (D:A:D): A multicohort collaboration 81
Temporin A is effective in MRSA-infected wounds through bactericidal activity and acceleration of wound repair in a murine model. 81
In-vitro activity of rifabutin and albendazolo singly and in combination with other clinically used antimicrobial agents against Pneumocystis carinii. 80
The antimicrobial peptide Tachyplesin III coated alone and in combination with intraperitoneal piperacillin-tazobactam prevents ureteral stent Pseudomonas infection in a rat subcutaneous pouch model 80
Synergistic effect of antimicrobial peptide LL-37 and colistin combination against multidrug-resistant Escherichia coli isolates 80
Daptomycin and Rifampin Alone and in Combination Prevent Vascular Graft Biofilm Formation and Emergence of Antibiotic Resistance in a Subcutaneous Rat Pouch Model of Staphylococcal Infection. 79
In vitro and in vivo activity of aurintricarboxylic acid preparations against Cryptosporidium parvum. 79
Urinary catheters and biofilm formation 79
Prevalence of predicted resistance to doravirine in HIV-1-positive patients after exposure to non-nucleoside reverse transcriptase inhibitors 79
An (Italian) proposal for a comprehensive approach to infections across the surgical pathway 79
Tocilizumab in COVID-19 interstitial pneumonia 79
In vitro activity of the synthetic lipopeptide PAL-Lys-Lys-NH(2) alone and in combination with antifungal agents against clinical isolates of Cryptococcus neoformans. 78
In vitro activity of citropin 1.1 alone and in combination with clinically used antimicrobial agents against Rhodococcus equi. 78
Antiendotoxin activity of antimicrobial peptides and glycopeptides. 78
BMAP-28 improves the efficacy of vancomycin in rat models of gram-positive cocci ureteral stent infection 76
Temporin A alone and in combination with imipenem reduces lethality in a mouse model of staphylococcal sepsis. 76
IB-367 pre-treatment improves the in vivo efficacy of teicoplanin and daptomycin in an animal model of wounds infected with meticillin-resistant Staphylococcus aureus 76
Long-term data on the efficacy and tolerability of lamivudine plus dolutegravir as a switch strategy in a multi-centre cohort of HIV-1-infected, virologically suppressed patients 76
In vitro and in vivo activity of fosfomycin alone and in combination with rifampin and tigecycline against Grampositive cocci isolated from surgical wound infections 75
Delayed wound healing in aged skin rat models after thermal injury is associated with an increased MMP-9, K6 and CD44 expression 75
Evolution and predictors of HIV type-1 drug resistance in patients failing combination antiretroviral therapy in Italy. 74
Amphibian Peptides Prevent Endotoxemia and Bacterial Translocation in Bile Duct-Ligated Rats 74
Interaction of antimicrobial peptide temporin L with lipopolysaccharide in vitro and in experimental rat models of septic shock caused by gram-negative bacteria. 74
Efficacy of Tigecycline and Rifampin Alone and in Combination against Enterococcus faecalis Biofilm Infection in a Rat Model of Ureteral Stent. 74
Incidence and progression to cirrhosis of new hepatitis C virus infections in persons living with human immunodeficiency virus. 74
Safety and efficacy of ombitasvir/paritaprevir/ritonavir/dasabuvir plus ribavirin in patients over 65 years with HCV genotype 1 cirrhosis 74
Clinical and epidemiological characteristics of KPC-producing Klebsiella pneumoniae from bloodstream infections in a tertiary referral center in Italy 74
Tollerabilità metabolica e durevolezza degli schemi antiretrovirali comprendenti nevirapina (Durability and tolerability of long-term nevirapine-based HAART). 73
Cathelicidin peptide sheep myeloid antimicrobial peptide-29 prevents endotoxin-induced mortality in rat models of septic shock 73
OpuC--an ABC transporter that is associated with Staphylococcus aureus pathogenesis. 73
In vitro activity of amphibian peptides alone and in combination with antimicrobial agents against multidrug-resistant pathogens isolated from surgical wound infection. 73
In vitro activity of MSI-78 alone and in combination with antibiotics against bacteria responsible for bloodstream infections in neutropenic patients. 73
Lipopeptide Laur-CKK-NH2 dimer preserves daptomycin susceptibility and enhances its activity against Enterococcus faecalis. 73
Incidence and factors associated with the risk of sexually transmitted diseases in HIV-infected people seen for care in Italy: Data from the Icona Foundation cohort 73
Acute hepatitis C: A 24-week course of pegylated interferon alpha-2b versus a 12-week course of pegylated interferon alpha-2b alone or with ribavirin 73
Impact of the M184V resistance mutation on virological efficacy and durability of lamivudine-based dual antiretroviral regimens as maintenance therapy in individuals with suppressed HIV-1 RNA: A cohort study 73
RNAIII-Inhibiting Peptide-Loaded Polymethylmethacrylate Prevents In Vivo Staphylococcus aureus Biofilm Formation 72
Role of daptomycin on burn wound healing in an animal methicillin-resistant staphylococcus aureus infection model 72
Evaluation of glomerular filtration rate in HIV-1-infected patients before and after combined antiretroviral therapy exposure. 71
Effect of the combination of clarithromycin and amikacin on Pseudomonas aeruginosa biofilm in a animal model of ureteral stent infection. 71
Vitamin E supplementation in old mice induces antimicrobial activity and improves the efficacy of daptomycin in an animal model of wounds infected with methicillin resistant Staphylococcus aureus. 71
In vitro activity and killing effect of the synthetic hybrid cecropin A-melittin peptide CA(1-7)M(2-9)NH(2) on methicillin-resistant nosocomial isolates of Staphylococcus aureus and interactions with clinically used antibiotics. 71
Administration of protegrin peptide IB-367 to prevent endotoxin induced mortality in bile duct ligated rats. 71
RNAIII-inhibiting peptide enhances healing of wounds infected with methicillin-resistant Staphylococcus aureus. 71
Effects of pexiganan alone and combined with betalactams in experimental endotoxic shock 71
Antiendotoxin activity of protegrin analog IB-367 alone or in combination with piperacillin in different animal models of septic shock 71
Cytomegalovirus coinfection is associated with an increased risk of severe non-AIDS-defining events in a large cohort of HIV-infected patients 71
Quorum Sensing Inhibitor FS3-coated Vascular Graft Enhances Daptomycin Efficacy in a Rat Model of Staphylococcal Biofilm Infection. 71
In vitro activities of tritrpticin alone and in combination with other antimicrobial agents against Pseudomonas aeruginosa. 70
Efficacy of tachyplesin III, colistin, and imipenem against a multiresistant Pseudomonas aeruginosa strain. 70
Pre-treatment of central venous catheters with the cathelicidin BMAP-28 enhances the efficacy of antistaphylococcal agents in the treatment of experimental catheter-related infection. 70
Antiseptic compounds still active against bacterial strains isolated from surgical wound infections despite increasing antibiotic resistance. 70
In- vitro activity of terbinafine, atovaquone and co-trimoxazole against Pneumocystis carinii. 70
Efficacy and tolerability of switching to a dual therapy with darunavir/ritonavir plus raltegravir in HIV-infected patients with HIV-1 RNA ≤50cp/mL. 70
Psoriasi e AIDS. A proposito di un caso. 69
Protective effects of the combination of alpha-helical antimicrobial peptides and rifampicin in three rat models of Pseudomonas aeruginosa infection. 69
The efficacy of the quorum sensing inhibitor FS8 and tigecycline in preventing prosthesis biofilm in an animal model of staphylococcal infection 69
Evolution of HIV-1 tropism at quasispecies level after 5 years of combination antiretroviral therapy in patients always suppressed or experiencing episodes of virological failure 69
Efficacy and tolerability of dolutegravir and two nucleos(t)ide reverse transcriptase inhibitors in HIV-1-positive, virologically suppressed patients 69
In vitro susceptibility of dermatophytes to conventional and alternative antifungal agents. 69
Ombitasvir, paritaprevir, and ritonavir, with or without dasabuvir, plus ribavirin for patients with hepatitis C virus genotype 1 or 4 infection with cirrhosis (ABACUS): a prospective observational study 69
Totale 8.407
Salva come PNG Salva come JPEG
Categoria #
all - tutte 110.713
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 110.713
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20201.208 0 0 0 0 0 21 309 18 316 62 52 430
2020/20214.597 246 475 611 62 500 297 433 304 475 482 479 233
2021/20222.534 215 546 25 124 34 174 125 150 167 299 195 480
2022/20234.010 418 374 297 276 284 655 7 210 1.035 20 307 127
2023/20242.318 435 48 139 384 409 474 34 63 21 28 37 246
2024/20251.718 661 424 290 132 166 45 0 0 0 0 0 0
Totale 19.873